Free Trial
CVE:BCT

BriaCell Therapeutics (BCT) Stock Price, News & Analysis

BriaCell Therapeutics logo
C$10.60 -0.42 (-3.81%)
As of 12/30/2021

About BriaCell Therapeutics Stock (CVE:BCT)

Key Stats

Today's Range
C$10.60
C$11.07
50-Day Range
C$10.60
C$10.60
52-Week Range
C$3.50
C$15.75
Volume
3,402 shs
Average Volume
12,671 shs
Market Capitalization
C$168.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$15.00
Consensus Rating
N/A

Company Overview

Receive BCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

BCT Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

BCT Stock Analysis - Frequently Asked Questions

BriaCell Therapeutics' stock was trading at C$10.60 on January 1st, 2025. Since then, BCT stock has increased by 0.0% and is now trading at C$10.60.

Shares of BCT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that BriaCell Therapeutics investors own include Brainstorm Cell Therapeutics (BCLI), Organovo (ONVO), BMO MSCI India ESG Leaders Index ETF (ZID), Athersys (ATHX), Anavex Life Sciences (AVXL), Cardium Therapeutics (CRXM) and Inovio Pharmaceuticals (INO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:BCT
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Price Target and Rating

High Price Target
C$15.00
Low Price Target
C$15.00
Potential Upside/Downside
+41.5%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$3.34 per share
Price / Cash Flow
3.17
Book Value
C$3.60 per share
Price / Book
2.94

Miscellaneous

Free Float
N/A
Market Cap
C$168.68 million
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (CVE:BCT) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners